The study explores the potential of chitosan derivatives as novel inhibitors against the wild-type and emerging variants of ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

SARS-CoV-2 infection was associated with more rapid coronary plaque progression and significantly increased risk for adverse ...

The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

The “Epicovid 2.0” study shows that the “impacts of the pandemic are great and long-lasting” and that it has “exacerbated ...

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...